Live Breaking News & Updates on Connect biopharma holdings limited

Stay informed with the latest breaking news from Connect biopharma holdings limited on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Connect biopharma holdings limited and stay connected to the pulse of your community

HC Wainwright Analysts Lift Earnings Estimates for Connect Biopharma Holdings Limited (NASDAQ:CNTB)

Connect Biopharma Holdings Limited (NASDAQ:CNTB – Free Report) – Investment analysts at HC Wainwright boosted their FY2024 EPS estimates for shares of Connect Biopharma in a research note issued to investors on Wednesday, April 17th. HC Wainwright analyst E. Bodnar now expects that the company will earn $1.63 per share for the year, up from […]

Biopharma-company-profile , Biopharma-holdings-limited , Invesco-ltd , Jpmorgan-chase-co , Biopharma-holdings , Vident-investment-advisory , Renaissance-technologies , Connect-biopharma-holdings-limited , Free-report , Connect-biopharma , Investment-advisory

Connect Biopharma (NASDAQ:CNTB) Trading Up 21.1%

Connect Biopharma Holdings Limited (NASDAQ:CNTB – Get Free Report) shot up 21.1% on Wednesday . The company traded as high as $1.65 and last traded at $1.61. 364,428 shares traded hands during mid-day trading, an increase of 191% from the average session volume of 125,443 shares. The stock had previously closed at $1.33. Wall Street […]

Invesco-ltd , Biopharma-holdings-limited , Renaissance-technologies , Biopharma-company-profile , Citadel-advisors , Biopharma-holdings , Blackrock-inc , Connect-biopharma-holdings-limited , Get-free-report , Connect-biopharma , Connect-biopharma-daily

Connect Biopharma (CNTB) Appoints James Huang to its Board

Connect Biopharma (CNTB) Appoints James Huang to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Berkeley , California , United-states , Stanford , China , Bristol-myers-squibb , Kleiner-perkins , James-zuie-chin-huang , James-huang , University-of-california , Tularik-inc , Johnson

Leerink Partnrs Comments on Connect Biopharma Holdings Limited's FY2028 Earnings (NASDAQ:CNTB)

Leerink Partnrs Comments on Connect Biopharma Holdings Limited's FY2028 Earnings (NASDAQ:CNTB)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs , Biopharma-holdings-limited , Blackrock-inc , Biopharma-holdings , Renaissance-technologies , Citadel-advisors , Invesco-ltd , Connect-biopharma-holdings-limited , Free-report , Connect-biopharma , Biopharma-stock-down , Get-free-report

Connect Biopharma (NASDAQ:CNTB) Stock Price Up 4%

Connect Biopharma Holdings Limited (NASDAQ:CNTB – Get Free Report)’s share price was up 4% on Friday . The stock traded as high as $1.06 and last traded at $1.05. Approximately 19,142 shares traded hands during trading, a decline of 73% from the average daily volume of 71,243 shares. The stock had previously closed at $1.01. […]

Biopharma-holdings-limited , Biopharma-holdings , Renaissance-technologies , Jpmorgan-chase-co , Vident-investment-advisory , Biopharma-company-profile , Connect-biopharma-holdings-limited , Get-free-report , Investment-advisory , Connect-biopharma , Woodline-partners

Connect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 21.3% in January

Connect Biopharma Holdings Limited (NASDAQ:CNTB – Get Free Report) was the recipient of a large decline in short interest in January. As of January 15th, there was short interest totalling 127,500 shares, a decline of 21.3% from the December 31st total of 162,100 shares. Based on an average daily trading volume, of 378,100 shares, the […]

Biopharma-holdings-limited , Vident-investment-advisory , Biopharma-company-profile , Biopharma-holdings , Jpmorgan-chase-co , Renaissance-technologies , Connect-biopharma-holdings-limited , Get-free-report , Investment-advisory , Connect-biopharma , Woodline-partners

Connect Biopharma (CNTB) Reports Positive Rademikibart Global Phase 2b Topline Results

Connect Biopharma (CNTB) Reports Positive Rademikibart Global Phase 2b Topline Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South-korea , China , Poland , Oregon , United-states , Hungary , Edward-kerwin , Asthma-center , Biopharma-holdings-limited-nasdaq , Clinical-research-institute , Connect-biopharma-holdings-limited , Full-analysis-set

Connect Biopharma (CNTB) to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12

Connect Biopharma (CNTB) to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Edwardm-kerwin , Clinical-research-institute , Biopharma-holdings-limited-nasdaq , Asthma-center , Connect-biopharma-holdings-limited , Senior-medical-director , Altitude-clinical , Webcast-presentationdate , Connect-biopharma ,

Positive Long-Term Data Shown in Patients with Atopic Dermatitis Treated with Rademikibart

These pivotal trial results from a study in China indicated the potential of this drug as a quarterly treatment for individuals with eczema.

China , Zheng-wei , Anhui , Biopharma-holdings , Connect-biopharma-holdings-limited , Connect-biopharma , Biopharma-announces-positive-long-term-data , China-pivotal-trial , Moderate-to-severe-atopic , Eczema , Atopic-dermatitis

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Zheng-wei , Anhui , China , Hong-kong , Macau , Taiwan , Chinese , Jinsheng-ren , Biopharma-hong-kong , Simcere-pharmaceutical-co-ltd , Biopharma-holdings-limited-nasdaq , Simcere-pharmaceutical-group-ltd